Nanosonics LimitedASX: NAN

Nanosonics Receives FDA De Novo Clearance for CORIS

· Issued by Nanosonics Limited

Filed with ASX · · 1 page · English

Summary by 6ix AI

Nanosonics Limited announces that it has received FDA De Novo clearance for its CORIS system, which is designed to enhance cleaning outcomes for flexible endoscopes and reduce infection risks. The CORIS system aims to automate cleaning processes, addressing significant challenges in medical device reprocessing. The initial phase of commercialization is set to focus on market awareness and controlled releases in hospitals before broader distribution.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Nanosonics Limited on 6ix

Earlier from Nanosonics

Later from Nanosonics

All Nanosonics news releases